The CPhI Pharma Award for Excellence in Analysis, Testing, and Quality Control went to B&W Tek for its handheld laser induced breakdown spectroscopy (LIBS) analyzer, NanoLIBS, which has been developed for rapid identification of solid materials based on elemental analysis. The instrument features a raster scan using a high repetition rate class 3B laser allowing for detection of elements including C, Li, and Be.
The winning entry was Merck’s Emprove program, which facilitates risk assessment and supplier qualification by providing instant, online access to regulatory and technical information on hundreds of products used in pharmaceutical and biopharmaceutical manufacturing.
Pharmaceutical Technology Europe will be exhibiting at CPhI Worldwide at Stand 3G98.
Tapemark, a full-service CDMO specializing in transdermal, oral thin film, and topical drug-delivery technologies, is exhibiting at CPhI.
Ravi Limaye gives an overview of the biosimilar industry and projects for 2020.
Gil Roth gives an overview and outlook for the CDMO industry in 2016.
Alan Sheppard, Principal, Global Generics at IMS Health and CPhI expert panel member, discusses generic medicine opportunities in the 2016 CPhI Annual Industry Report.
Three-dimensional (3D) printing, which is a type of additive manufacturing (AM), enables fabrication of specialty drugs and medical devices, said Emil Ciurczak, Doramaxx Consulting and CPhI expert panel member, in the 2016 CPhI Annual Industry Report.
The CDMO has acquired a new building to expand its high-containment manufacturing and development operations.
Sharp will present alongside Tracelink, Systech, Covectra, and Domino during CPhI Worldwide.
Containing costs and improving compliance will be crucial to ensuring the growth of generic pharmaceuticals in the future, says Dilip Shah, CEO of Vision Consulting Group, in CPhI’s 2016 Annual Report, which will be formally issued at CPhI 2016 in Barcelona.
The next decade of drug development will depend on better ways of storing, using, and analyzing data, says CPhI advisor Bikash Chatterjee, president and chief science officer of Pharmatech Associates. But each of the following must be optimized: volume, variety, velocity, veracity, and value.
The choice of metrics used to measure the performance of a pharmaceutical operation are crucial, and should be systems oriented.
The current approach of classifying process parameters and quality attributes as critical or non-critical is too simplistic to adequately reflect current science and risk-based approaches to product quality.
Employee empowerment is needed and it begins with senior leaders making adherence to cGMP regulations and compliance with SOPs the normal, easy, and rewarding thing to do.
Pharma’s lack of manufacturing innovation is its biggest shortcoming; but like any other business, investment in this area will need to be justified.
PCI will be participating in two Speakers Corner slots at the ICSE Exhibitor Showcase.
West will showcase several drug-delivery systems and packaging component technologies such as its NovaPure plungers and SmartDose technology platform.
Aptar Stelmi will present PremiumCoat, an alternative coated stopper for sensitive drugs, at CPhI 2016.
The company sees a demand for customized individual packaging solutions as the pharmaceutical manufacturing industry moves towards smaller lot sizes that require aspects of individualization.
CPhI announced the finalists in all 12 categories for the 2016 excellence in pharma awards.
The company will debut its multi-dosage weight checker at the October show.
CPhI outlines trends from the conference in Seoul.
The Gx RTF ClearJect syringe is made of cyclic olefin copolymer and is tungsten- and adhesive-free.
Analysts examine the latest trends in finished dosage forms.
The company will be releasing its new 3C technology for omega 3 EPA and DHA at CPhI Worldwide.
The company will showcase its injectable grade pharmaceutical oils at CPhI Worldwide.
The company will display new products such as the Opadry QX, a tablet film coating.
The panel includes 12 experts from a variety of disciplines.
Michael Platscher, senior project manager R&D, Drug Delivery Compounds-Lipids, Merck & Cie, shares about his experience as a judge for the CPhI Pharma Awards.